All Stories

  1. Mechanistic Studies and Formulation Mitigations of Adeno-associated Virus Capsid Rupture During Freezing and Thawing
  2. Impact of Time Out of Intended Storage and Freeze-thaw Rates on the Stability of Adeno-associated Virus 8 and 9
  3. Quantitation of Trace Levels of DNA Released from Disrupted Adeno-Associated Virus Gene Therapy Vectors
  4. Energetic Dissection of Mab-Specific Reversible Self-Association Reveals Unique Thermodynamic Signatures
  5. Analytical characterization of coformulated antibodies as combination therapy
  6. Monoclonal Antibody Dimers Induced by Low pH, Heat, or Light Exposure Are Not Immunogenic Upon Subcutaneous Administration in a Mouse Model
  7. Investigation of cathepsin D–mAb interactions using a combined experimental and computational tool set
  8. Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice
  9. Determination of Interaction Parameters for Reversibly Self-Associating Antibodies: A Comparative Analysis
  10. Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody
  11. Development of Prefilled Syringe Combination Products for Biologics
  12. Biophysical characterization of influenza A virions
  13. Impact of Mutations on the Higher Order Structure and Activity of a Recombinant Uricase
  14. Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
  15. Identification of an IgG CDR sequence contributing to co-purification of the host cell protease cathepsin D
  16. Generation and Characterization of an IgG4 Monomeric Fc Platform
  17. Fate of Multimeric Oligomers, Submicron, and Micron Size Aggregates of Monoclonal Antibodies Upon Subcutaneous Injection in Mice
  18. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product
  19. Technical Decision Making with Higher Order Structure Data: Impact of a Formulation Change on the Higher Order Structure and Stability of a mAb
  20. Gelation of a Monoclonal Antibody at the Silicone Oil–Water Interface and Subsequent Rupture of the Interfacial Gel Results in Aggregation and Particle Formation
  21. Characterization of Monoclonal Antibody Aggregates and Emerging Technologies
  22. Characterization of the Initial Level and Migration of Silicone Oil Lubricant in Empty Prefilled Syringes for Biologics Using Infrared Spectroscopy
  23. Protein Aggregation and Particle Formation in Prefilled Glass Syringes
  24. Partial Unfolding of a Monoclonal Antibody: Role of a Single Domain in Driving Protein Aggregation
  25. Ionic Strength Affects Tertiary Structure and Aggregation Propensity of a Monoclonal Antibody Adsorbed to Silicone Oil–Water Interfaces
  26. The future of protein particle characterization and understanding its potential to diminish the immunogenicity of biopharmaceuticals: A shared perspective
  27. Computational fluid dynamics (CFD) insights into agitation stress methods in biopharmaceutical development
  28. Production of particles of therapeutic proteins at the air–water interface during compression/dilation cycles
  29. Effects of Surfaces and Leachables on the Stability of Biopharmaceuticals
  30. Aggregation of a monoclonal antibody induced by adsorption to stainless steel
  31. Precipitation of a Monoclonal Antibody by Soluble Tungsten
  32. Monoclonal antibody interactions with micro- and nanoparticles: Adsorption, aggregation, and accelerated stress studies
  33. Response of a concentrated monoclonal antibody formulation to high shear
  34. Variable Dimensionality in the Uranium Fluoride/2-Methyl-Piperazine System:  Syntheses and Structures of UFO-5, -6, and -7; Zero-, One-, and Two-Dimensional Materials with Unprecedented Topologies